|Mr. George Achilleos||CEO & Pres||27.17k||N/A||N/A|
|Mr. Daniel Gallucci||Founder, Chief Innovation Officer & Director||67.66k||N/A||1977|
|Dr. Joseph Geraci Ph.D.||Chief Scientific Officer||N/A||N/A||N/A|
|Ms. Jaime Hackett||VP of Marketing||N/A||N/A||N/A|
|Dr. Luca Pani M.D.||Chief Medical Advisor & Member of Mental Health Advisory Council||N/A||N/A||N/A|
|Dr. Kaveh Kavoosi||Head of Progressive Medicine||N/A||N/A||N/A|
|Mr. Mark Smithyes||Pres of NetraMark||N/A||N/A||1970|
Nurosene Inc., a technology-driven wellness company, focuses on developing a line of proprietary nutraceuticals in Canada. It develops nutraceuticals, including Nuro Drive, a product to enhance physical and cognitive energy levels; Nuro Restore, a product to improve sleep, as well as reduce stress, and pain and inflammation. The company is also developing a virtual care mobile application to provide continuous support to those suffering from mental health issues. Nurosene Inc. was incorporated in 2019 and is headquartered in Toronto, Canada.
Nurosene Health Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.